JLE

Epileptic Disorders

MENU

Relationship between tumour location and preoperative seizure incidence in patients with gliomas: a systematic review and meta-analysis Volume 17, numéro 4, December 2015

  • [Chang et al., 2008] Chang E.F., Potts M.B., Keles G.E. Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg. 2008;108:227-235. 2
  • [de Groot and Sontheimer, 2011] de Groot J., Sontheimer H. Glutamate and the biology of gliomas. Glia. 2011;59:1181-1189. 8
  • [Higgins and Thompson, 2002] Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-1558. 11
  • [Huang et al., 2011] Huang L., You G., Jiang T., Li G., Li S., Wang Z. Correlation between tumor-related seizures and molecular genetic profile in 103 Chinese patients with low-grade gliomas: a preliminary study. J Neurol Sci. 2011;302:63-67. 1-2
  • [Huang et al., 2014] Huang C., Li H., Chen M., Si Y., Lei D. Factors associated with preoperative and postoperative epileptic seizure in patients with cerebral ganglioglioma. Pak J Med Sci. 2014;30:245-249. 2
  • [Iuchi et al., 2015] Iuchi T., Hasegawa Y., Kawasaki K., Sakaida T. Epilepsy in patients with gliomas: incidence and control of seizures. J Clin Neurosci. 2015;22:87-91. 1
  • [Jamal et al., 2015] Jamal M., Ono J., Ameno K. Aldehyde dehydrogenase 2 deficiency increases resting-state glutamate and expression of the GluN1 subunit of N-methyl-D-aspartate receptor in the frontal cortex of mice. J Neurol Sci. 2015;348:46-50. 1-2
  • [Kaloshi et al., 2009] Kaloshi G., Psimaras D., Mokhtari K. Supratentorial low-grade gliomas in older patients. Neurology. 2009;73:2093-2098. 24
  • [Kerkhof and Vecht, 2013] Kerkhof M., Vecht C.J. Seizure characteristics and prognostic factors of gliomas. Epilepsia. 2013;54:12-17. 9
  • [Lee et al., 2010] Lee J.W., Wen P.Y., Hurwitz S. Morphological characteristics of brain tumors causing seizures. Arch Neurol. 2010;67:336-342. 3
  • [Liubinas et al., 2014] Liubinas S.V., D’Abaco G.M., Moffat B.M. IDH1 mutation is associated with seizures and protoplasmic subtype in patients with low-grade gliomas. Epilepsia. 2014;55:1438-1443. 9
  • [Maschio and Dinapoli, 2012] Maschio M., Dinapoli L. Patients with brain tumor-related epilepsy. J Neurooncol. 2012;109:1-6. 1
  • [Maurice and Mason, 2014] Maurice C., Mason W.P. Seizure management in patients with gliomas. Expert Rev Neurother. 2014;14:367-377. 4
  • [Musazzi et al., 2015] Musazzi L., Treccani G., Popoli M. Functional and structural remodeling of glutamate synapses in prefrontal and frontal cortex induced by behavioral stress. Front Psychiatry. 2015;6:60.
  • [Pallud et al., 2014] Pallud J., Audureau E., Blonski M. Epileptic seizures in diffuse low-grade gliomas in adults. Brain. 2014;137:449-462. 2
  • [Prayson, 2010] Prayson R.A. Diagnostic challenges in the evaluation of chronic epilepsy-related surgical neuropathology. Am J Surg Pathol. 2010;34:e1-e13.
  • [Riva et al., 2006] Riva M., Salmaggi A., Marchioni E. Tumour-associated epilepsy: clinical impact and the role of referring centres in a cohort of glioblastoma patients. A multicentre study from the Lombardia Neurooncology Group. Neurol Sci. 2006;27:345-351. 5
  • [Rossetti and Stupp, 2010] Rossetti A.O., Stupp R. Epilepsy in brain tumor patients. Curr Opin Neurol. 2010;23:603-609. 6
  • [Rudà et al., 2012] Rudà R., Bello L., Duffau H., Soffietti R. Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments. Neuro Oncol. 2012;14:iv55-iv64. 4
  • [Sirven et al., 2004] Sirven J.I., Wingerchuk D.M., Drazkowski J.F., Lyons M.K., Zimmerman R.S. Seizure prophylaxis in patients with brain tumors: a meta-analysis. Mayo Clin Proc. 2004;79:1489-1494. 12
  • [Stockhammer et al., 2012] Stockhammer F., Misch M., Helms H.J. IDH1/2 mutations in WHO grade II astrocytomas associated with localization and seizure as the initial symptom. Seizure. 2012;21:194-197. 3
  • [Wang et al., 2015] Wang Y., Qian T., You G. Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping. Neuro Oncol. 2015;17:282-288. 2
  • [Wells et al., 2015] Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. Ottawa Health Research Institute. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed 15 May 2015)
  • [Yang et al., 2014] Yang P., You G., Zhang W. Correlation of preoperative seizures with clinicopathological factors and prognosis in anaplastic gliomas: a report of 198 patients from China. Seizure. 2014;23:844-851. 10
  • [You et al., 2012] You G., Sha Z.Y., Yan W. Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of low-grade gliomas: a clinicopathological study. Neuro Oncol. 2012;14:230-241. 2
  • [Yuen et al., 2012] Yuen T.I., Morokoff A.P., Bjorksten A. Glutamate is associated with a higher risk of seizures in patients with gliomas. Neurology. 2012;79:883-889. 9
  • [Zhong et al., 2015] Zhong Z., Wang Z., Wang Y., You G., Jiang T. IDH1/2 mutation is associated with seizure as an initial symptom in low-grade glioma: a report of 311 Chinese adult glioma patients. Epilepsy Res. 2015;109:100-105.